SCHEMBL27147161

SCHEMBL27147161

Fc1c(Br)c(Cl)cc2c(N3CCCCCC3)nc(Cl)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 2/20 0.44
ALOX15 P16050 2/20 0.38
LMNA P02545 1/20 0.38
PRNP P04156 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
PPARG P37231 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NR2E3 Q9Y5X4 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
MAT2A P31153 2/20 0.35
HRH3 Q9Y5N1 3/20 0.34
ABCB1 P08183 1/20 0.33
MEN1 O00255 1/20 0.33
GFER P55789 1/20 0.33
KMT2A Q03164 1/20 0.33
FABP4 P15090 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17030874 1.00 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1ALOX15LMNAPRNP
SCHEMBL30922651 0.89 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1ALOX15LMNAPRNP
SCHEMBL25081570 0.88 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1LMNAMAPTTSHR
SCHEMBL19695842 0.87 HTR2C (0.40) MAPTHTTHRH3MEN1KMT2A
SCHEMBL19422066 0.87 SMN1; SMN2 (0.47) SMN1; SMN2HTTHRH3KMT2A
SCHEMBL25253238 0.86 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1TSHRHRH3MEN1
SCHEMBL18133893 0.85 TLR7 (0.46) SMN1; SMN2ALDH1A1ALOX15LMNAPRNP
SCHEMBL25165073 0.85 SGK1 (0.34) SMN1; SMN2ALDH1A1LMNATSHRHTT
SCHEMBL31470355 0.84 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1MAT2A
SCHEMBL27100910 0.84 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1ALOX15LMNAPRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083750-A1 SMALL MOLECULE INHIBITORS OF KRAS PROTEINS MERCK SHARP & DOHME LLC 2026-03-26 US disclosed
EP-4577214-A2 SMALL MOLECULE INHIBITORS OF KRAS PROTEINS Merck Sharp & Dohme LLC (US) 2025-07-02 EP disclosed
WO-2024044667-A2 SMALL MOLECULE INHIBITORS OF KRAS PROTEINS MERCK SHARP & DOHME LLC (US) 2024-02-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083750-A1 SMALL MOLECULE INHIBITORS OF KRAS PROTEINS KRAS, NRAS, RASGRP1 SMN1; SMN2 593/4885ALDH1A1 3539/4885ALOX15 4405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.